Medicare Part D coverage · nitisinone · RxCUI 2719722
nitisinone 2 MG Oral Tablet [Harliku]
Per the CMS 2026 Part D formulary file, nitisinone 2 MG Oral Tablet [Harliku] is covered by 157 Medicare Part D plans (3.1% of enrollable products), averaging Tier 4.3, with prior authorization required on 81.8% of covering formularies.
- 3.1%
- Plan coverage
- 157
- Plans covering
- T4.3
- Avg tier
- 81.8%
- Prior auth required
What the CMS Formulary Data Shows for nitisinone 2 MG Oral Tablet [Harliku]
Per the CMS 2026 Part D formulary file, nitisinone 2 MG Oral Tablet [Harliku] (RxNorm concept RXCUI 2719722, generic name nitisinone) appears on 11 distinct formulary files spanning 157 Medicare Part D plan offerings - 3.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.3.
Real-world access to nitisinone 2 MG Oral Tablet [Harliku] depends on utilization management as much as tier placement: 81.8% of covering formularies require prior authorization. 0% require step therapy. 54.5% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nitisinone 2 MG Oral Tablet [Harliku] today.
Coverage Details
- Formularies covering
- 11
- Plans covering
- 157
- Coverage rate
- 3.1%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 81.8% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 54.5% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering nitisinone 2 MG Oral Tablet [Harliku]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| UPMC for Life HMO Premier Rx (HMO) | Upmc Health Plan, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | Yes | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | Yes | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life PPO Essential Care Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc Health Coverage, Inc. | T5 | Yes | $0 | PA |
| Kaiser Permanente Senior Advantage LA, Orange Co. (HMO) | Kaiser Foundation HP, Inc. | T5 | No | $0 | CA |
| Kaiser Permanente Senior Advantage Enhanced Solano (HMO) | Kaiser Foundation HP, Inc. | T5 | No | $0 | CA |
| Kaiser Permanente Senior Advantage Inland Empire (HMO) | Kaiser Foundation HP, Inc. | T5 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is nitisinone 2 MG Oral Tablet [Harliku] covered by Medicare Part D?
Yes, nitisinone 2 MG Oral Tablet [Harliku] is covered by 157 Medicare Part D plans (3.1% of all Part D formularies).
What tier is nitisinone 2 MG Oral Tablet [Harliku] on Medicare Part D plans?
nitisinone 2 MG Oral Tablet [Harliku] averages Tier 4.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does nitisinone 2 MG Oral Tablet [Harliku] require prior authorization?
81.8% of Part D formularies require prior authorization for nitisinone 2 MG Oral Tablet [Harliku]. Step therapy: 0%. Quantity limits: 54.5%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- sapropterin dihydrochloride 100 MG Powder for Oral Solution T4.3
- C1 esterase inhibitor (human) 2000 UNT Injection [Haegarda] T4.3
- tolvaptan 15 MG Oral Tablet T4.3
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] T4.3
- pirfenidone 534 MG Oral Tablet T4.3
- 0.5 ML ustekinumab 90 MG/ML Prefilled Syringe [Stelara] T4.3